000 | 01997 a2200577 4500 | ||
---|---|---|---|
005 | 20250515195043.0 | ||
264 | 0 | _c20100315 | |
008 | 201003s 0 0 eng d | ||
022 | _a1524-4571 | ||
024 | 7 |
_a10.1161/CIRCRESAHA.109.211797 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTao, Ling | |
245 | 0 | 0 |
_aAdiponectin: an indispensable molecule in rosiglitazone cardioprotection following myocardial infarction. _h[electronic resource] |
260 |
_bCirculation research _cFeb 2010 |
||
300 |
_a409-17 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAdipocytes _xmetabolism |
650 | 0 | 4 |
_aAdiponectin _xblood |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aCapillaries _xdrug effects |
650 | 0 | 4 |
_aCardiotonic Agents _xpharmacology |
650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHeart Function Tests |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacology |
650 | 0 | 4 | _aIn Situ Nick-End Labeling |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Knockout |
650 | 0 | 4 |
_aMyocardial Infarction _xpathology |
650 | 0 | 4 |
_aPPAR gamma _xagonists |
650 | 0 | 4 |
_aPlatelet Endothelial Cell Adhesion Molecule-1 _xmetabolism |
650 | 0 | 4 | _aReverse Transcriptase Polymerase Chain Reaction |
650 | 0 | 4 | _aRosiglitazone |
650 | 0 | 4 | _aSurvival Analysis |
650 | 0 | 4 |
_aThiazolidinediones _xpharmacology |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xblood |
700 | 1 | _aWang, Yajing | |
700 | 1 | _aGao, Erhe | |
700 | 1 | _aZhang, Hangxiang | |
700 | 1 | _aYuan, Yuexing | |
700 | 1 | _aLau, Wayne B | |
700 | 1 | _aChan, Lawrence | |
700 | 1 | _aKoch, Walter J | |
700 | 1 | _aMa, Xin L | |
773 | 0 |
_tCirculation research _gvol. 106 _gno. 2 _gp. 409-17 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1161/CIRCRESAHA.109.211797 _zAvailable from publisher's website |
999 |
_c19324254 _d19324254 |